Nanoparticles overcome adaptive immune resistance and enhance via targeting tumor microenvironment in lung cancer

HIGHLIGHTS

• who: TME et al. from the Nanjing Medical University, China have published the research work: Nanoparticles overcome adaptive immune resistance and enhance via targeting tumor microenvironment in lung cancer, in the Journal: (JOURNAL)
• what: This work showed that CCL7 enhanced anti-PD-1 therapy in these mouse models via promoting conventional DC 1 into TME, leading to T_cell expansion.
• how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
• future: Investigation is required . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.